Research
Hormonal
GLP-1 receptor agonists promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and obesity.
GLP-1 receptor agonists can be considered for managing type 2 diabetes and obesity in clinical practice.
StrongSupportsmedium confidence
Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and obesity.
Why this rating
Based on large-scale randomized, controlled trials mentioned in the abstract.
Source
GLP-1 Receptor Agonists
Clifford J. Rosen et al. · New England Journal of Medicine · 2026
reviewCited 3×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →